NR4A1 and breast cancer: On the other hand, the CRCs of hormone receptor (HR)+/HER2- tumors, presented lower number of CNAs and less complexes array-CGH profiles (except case 2), compatible to what is reported in the intrinsic molecular luminal A breast cancer subtype [20–23].